New shot promises brighter, less dry skin – but does it work?

NCT ID NCT07179198

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests an injectable solution called Kytogen Defend (KIO021) to see if it safely improves dry skin and dull complexion on the face. About 500 adults with these skin concerns will either receive the injection or no treatment. The goal is to measure visible skin improvement over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

KIO021 (carboxymethyl chitosan injectable solution)

What this could lead to

If it works, this could offer a temporary, non-surgical option to improve facial skin dryness and dullness.

What could go wrong

This is an early-stage trial with no prior results, so the treatment may not work better than no treatment. Risks from injections include swelling, redness, or infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN QUALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••